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Based on the histologic aspects of the lesions, primary
nephrosis with focal glomerular sclerosis has been classified
into focal segmental glomerulosclerosis (FSG) and focal global
glomerulosclerosis (FGG).
Several reports [1—141 define its clinical presentation and
attempt to identify the initial signs that indicate a poor progno-
sis. The criteria indicating poor prognosis were reported to be
age of onset [15, 16]. the presence ofa nephrotic syndrome [10.
15, 17], mesangial proliferation [14], the presence of focal
segmental glomerulosclerosis on early biopsies [171. the associ-
ation of glomerulotubular imbalance [18], the severity of the
lesions on an early biopsy (1—3. 5, 6, 8, 10, 12, 13, 17], and
especially the resistance of these patients to corticosteroid and
immunosuppressive therapy [1—3, 6, 8, 9, 11—13, 16, 17].
The long-term followup of children with focal glomerular
sclerosis has been analyzed in detail, however, only in a few
articles [2, 3, 17], and these reports have concluded that the
prognosis is generally poor.
The purpose of our study is to report the outcome of
observing 32 children with primary nephrosis and focal glomer-
ular sclerosis over a period of several years. We observed that
the long-term prognosis in our series is niore favorable than that
described by other reports. We believe that this discrepancy is
due to the referral profile of our institution and that our
population of patients more accurately reflects the full spectrum
of the natural history of the disease.
Methods
Between 1966 and 1979, 32 patients with primary nephrosis
and focal glomerular sclerosis were diagnosed in our unit. Some
of these patients were already sick for a few years before their
transfer to our unit. The patients who did not enter the dialysis
program or died, were observed for a mean period of8 years [I--
19] and were all evaluated during the year 1979. All biopsies
were examined by the same pathologist (MP). The examination
included light and immunofluorescence microscopy in all cases,
and electron microscopy in half of the cases. Of the 32 patients,
25 had histological lesions of FSG and 7 of FGG. The clinical
presentation was not different from the classical clinical presen--
tation described in previous reports. In the group of children
with histological lesions of FSG, there were 16 boys and 9 girls.
The mean age of onset was 5 years (range, 0.5 to 14.5 years). All
of the children examined revealed the nephrotic syndrome.
Hypertension was found in II children, macroscopic hernatu-
na in 4 cases, and microscopic hematuria in 14. Evidenee of
glomerulotubular imbalance such as glycosuria or tetan was
present in 5 of the 25 patients.
In the group of nephrotic children exhibiting histological
lesions of FGG, there were 3 males and 4 females. The mean
age of onset was 2 years (1.7 months to 5 years). Hypertension
was found in 4 patients. No child had gross hematuria on the
initial examination. However, one child had microscopic hema-
tuna.
Of the 32 patients, 19 had more than one biopsy. In 12 cases,
the histological diagnosis was the same as the initial one. The
initial biopsy of 3 patients was read as minimal lesion. and
subsequently as FSG. These second biopsies were performed
within 2 years of initial detection of the disease suggesting a
missed lesion on the first biopsies. Two patients had mesangial
hypercellulanity in the first biopsy and FSG or FOG in the
second biopsy done within 5 years of the onset. All the irititial
biopsies were performed within 2 years of initial signs of the
disease. Interestingly. 4 patients out of a total of 5 who had
mesangial hypercellularity rapidly progressed to chronic renal
failure.
Response of the patients with FSG to steroid therapy was as
follows: 6 responded completely to prednisone, I had a partial
response, 16 failed to respond, and I was not treated with
steroids. Of these patients, 17 subsequently received cyclo-
phosphamide; 6 responded to therapy and II did not. The
patients who responded to cyclophosphamide are also those
who had previously responded to prednisone therapy.
Of the patients with FOG, 6 responded to prednisone and I
was not treated. The 6 who responded to prednisone subse-
quently responded to cyclophosphamide therapy.
The remission induced by cyclophosphamide. however, was
much longer than that induced by prednisone. For patients with
FSG, the mean duration of remission induced by prednisone
was 1.5 months (0.5 to 3 months) whereas remission with
cyclophosphamide averaged 44 months (4 to 144 months). Of
the patients with FGG, prednisone therapy induced a mean
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Fig. 1.Actuarial survival curve for 25 children with FSG. The number of
patients available for analysis at each point is given at the top, and time
of death or entry into rena/failure is given at the bottom. The insert bar
graph summarizes the status at the last observation.
duration of remission of 10 months (I to 36 months) whereas
cyclophosphamide induced a remission of 52 months (30 to 120
months).
Results
Maintaining our purpose of evaluating long-term followups,
Figure 1 depicts the present status of the patients with FSG. Of
the 25 patients, 6(24%) are now in remission. The disease lasted
an average of 3.6 years (1 to 8 years) in the patients in
remission. The period of observation after remission averaged
3.8 years (1 to 13 years). Ten patients (40%) showed satisfac-
tory renal function (creatinine clearance over 50 mI/mm per I .73
m2. Half of these 10 still have persistent proteinuria (PP), and
half have recurrent nephrosis (NS). The mean period of obser-
vation is 7.3 years (0.5—19 years). Five patients (20%) required
dialysis and transplantation (DT). All these children entered the
dialysis program less than 4 years after the onset of the disease.
Three patients (12%) died from non-renal causes while they
were immuno-suppressed with normal renal functions: I from
chickenpox and 2 from septicemia. One patient is in chronic
renal failure.
The long-term prognosis of the patients exhibiting FGG is
more favorable. Of 7 patients, 4 are in remission (57%). Of the
group in remission, the disease lasted from I to 2 years and the
duration of remission averaged 6 years (2 to 10 years). Two
patients (29%) have a creatinine clearance above 50 mI/mm per
1.73 m2 but show persistent proteinuria. The duration of
followup of these 2 patients is 10.5 years (9 to 12 years). Finally,
one patient with histological lesions of FGG is in chronic renal
failure having a creatinine clearance of 30 mI/mm per 1.73 m2.
The actuarial survival curve of the patients with FSG was
calculated by the method of Cutler and Ederer [19]. Because
none of our patients with histologic lesions of FGG died or is on
dialysis, the curve was not designed for this particular sub-
group. Figure 1 shows only the survival curve for the patients
with FSG. The 68% survival rate depicted in this figure refers to
the percentage of patients who have not gone into terminal
failure or who have not died from non-renal causes. This rate
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Fig. 2. Serialcreatinine clearances of patients with focal glomeruloscle-
rosis who survive. Points represent the average creatinine clearance of
patients in each group observed in this specific year after detection of
the disease. After 3 years, the children in remission have a normal GFR
whereas the children with PP or recurrent NS maintain a lower level of
GFR. Asterisks (*) denote statistical significance.
was reached 4 years after the onset of the disease and remains
stable after 19 years of observation.
Serial creatinine clearances have been measured in patients
either in remission or with PP or recurrent NS. The creatinine
clearances were measured by the technique of Schwartz et al
[20]. The mean is reported in Figure 2. Twenty patients, 10 with
PP and 10 with recurrent NS have been observed for longer
than 2 years. It is interesting to note that 2 years after the onset,
both groups showed creatinine clearances between 60 and 80
mI/mm per 1.73 m2, and there is no significant difference
between those with PP or NS and the patients who have
subsequently recovered. However, 3 years or more after the
initial stages of the disease, there is a significant difference
between the mean creatinine clearance of both groups (P <
0.02). The patients in remission returned to normal, whereas the
patients with PP or recurrent NS stabilized at a lower creatinine
clearance ranging from 70 to 80 mI/mm per 1.73 m2. The values
do not reach significance every year because, for certain years,
the number of patients observed in one group or the other is not
large enough. These data suggest that in the group of patients
with "normal" renal function and persisting PP or NS, the
disease does not slowly progress to renal failure, although one
might suppose it progresses in a stepwise fashion.
Discussion
The first important conclusion of our study is that the
survival of our patients with FSG is more favorable than that
reported by other studies. Our group of patients presented with
a classical clinical picture. However, 32% entered dialysis or
transplantation or died within 4 years after the onset. Thereafter
our survival curve remained stable and plateaued at 68% up to
19 years of observation. Cameron et al (171 described a series of
children with an 18% survival rate 10 years after the onset
whereas Habib et al t2, 31 reported a 50% survival rate 16 years
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after the onset of the disease. The difference between our
results and those of others does not stem from the fact that our
patients had a different clinical presentation; all of our children
exhibited a nephrotic syndrome, and their clinical presentation
was no different with respect to age of onset, the presence of
hematuria or hypertension, severity of histologic lesions, and
response to prednisone and cyclophosphamide therapy. We do
believe, however, that the observed difference in outcome may
be due to a certain selection of the patients reported in other
groups because of their referral systems.
In general, most severe patients will be referred to special-
ized centers. The previous reports in the literature concerning
long-term followup of FSG have been either from Les Enfants
Malades in Paris or Guy's Hospital in London, both being
highly specialized referral centers. Our nephrology unit at St.
Justine Hospital has been in existence for 15 years only. It has
been initially utilized by general pediatricians as a general
referral Center. and this is well illustrated by the fact that of 300
renal biopsies performed on children suffering from primary
nephrosis, 83% had minimal glomerular lesions, which is much
higher than the statistics reported by the previously quoted
centers [I, II, 121. A judicious continuing education program to
pediatricians has slowly changed the referral system of our
institution.
In recent years, our referred population of children with
primary nephrosis has changed. Recent patients seem to be
more severely ill than the initial ones. This phenomenon is
illustrated by the fact that between 1966 and 1970, 87% (5 1/59)
of all biopsies performed on children with primary nephrosis
showed minimal glomerular lesions whereas between 1975 and
1979, this percentage fell to 76% (72/95).
Our long-term study of focal glomerular sclerosis probably
more accurately represents a broader spectrum of the disease.
We believe that the more favorable results are a reflection of
this wider range of patients. Our conclusion extends the results
observed by White et al [12] whose analysis of referred patients
with primary nephrosis showed minimal glomerular lesions in
64% of the patients and focal glomerulosclerosis in 11% where-
as unselected nephrotics showed minimal glomerular lesions in
88% of the patients and focal glomerulosclerosis in 5.3%.
Because of the difference in histological aspects, more of the
White et al unselected patients responded to corticosteroid
therapy than the selected patients. The study of Habib et al [I,
21 indicated that after 16 years of observation, the actuarial
survival curve of patients with FGG is as poor as the ones with
FSG. In that particular study, however, there are very few
patients with FGG observed for such a long period. We do not
have in our own study enough patients with FGG to analyse
results 15 years after the onset. As mentioned above, none of
the 7 patients with FGG has not yet decreased his glomerular
filtration rate under 20 mI/mm per 1.73 m2.
Moreover, the rapid deterioration of 32% of the patients with
FSG and the stable creatinine clearance of the other 68%
suggest that the disease in our group of patients may progress in
a stepwise fashion, each period of reactivation bringing a
decrease in the glomerular filtration rate.
These long-term results are believed to be a more faithful
reflection of the population observed than any specific differ-
ence either in the clinical or histologic type of presentation, or
in the treatment itself.
Summary. In our study, 32 nephrotic children with focal
glomerular sclerosis were observed for an average period of 8
years (ranging 1—19 years of age). Of the 32, 25 children showed
histological lesions of focal segmental sclerosis (FSG) and 7 of
focal global glomerulosclerosis (FGG). All patients were re-
evaluated in 1979, creating the most recent status as follows: for
children with FSG, 6 (24%) are in remission, 10 (40%) have a
relatively normal renal function but exhibit either a persisting
proteinuria (PP) or a recurrent nephrotic syndrome (NS), 1(4%)
is in chronic renal failure, 5 (20%) required dialysis and trans-
plantation, and 3 (12%) died from non-renal causes. For chil-
dren with FGG, 4 (57%) are in remission, 2 (29%) have a good
renal function but display either PP or NS, and I patient (14%)
is in chronic renal failure.
The long-term observation of our study shows a more favor-
able prognosis than the one reported in researched literature.
We believe that such results reflect a difference in the type of
population encountered in our institution. Our population of
patients represents less a highly referred population than the
one of the centers who reported similar long-term studies, and
we believe therefore that our study may represent a wider
spectrum of the natural history of the disease.
Moreover, the group of patients with PP or NS does not show
a progressive decrease of glomerular filtration rate with time,
which suggests that the disease may progress in a stepladder
fashion.
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